“We are grateful for the China government’s determination to fight cancer and its recognition of the positive impact of radiotherapy treatments,” said Dow Wilson, president and chief executive officer, Varian. “Varian envisions a world without fear of cancer, and we are committed to empowering our users to achieve new victories against cancer with our cancer care solutions. The exemption allows us to continue to focus on the fight against cancer.”
Varian is in its quiet period but will evaluate if further comments are necessary after completing its assessment of the impact of this exclusion, including the timing and process for any refunds. The company’s fiscal year 2019 earnings conference call is scheduled for Wednesday, October 23, 2019 at 1:30pm Pacific Time.
For more information, visit www.varian.com.